glp-1 receptor agonist nausea diarrhea management Gastrointestinal adverse events associated with RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis GLP-1 Receptor Agonists Shift: Oral

PMC 2014937

You can search for open trials at clinicaltrials.gov using the search terms retatrutide or LY3437943. General eligibility criteria for most TRIUMPH trials include: BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related condition No use of other weight loss medications in the prior 90 days No personal or family history of medullary thyroid carcinoma or MEN-2 No recent pancreatitis, heart attack, or stroke (within the prior 90 days) No prior bariatric surgery A note on online sales: The FDA has issued warnings about illegal websites selling substances that claim to be retatrutide

Pediatr Nephrol

Individual variation is significant based on compliance, starting composition, and metabolic response

Legal limits for BAC levels vary by jurisdiction, with higher BAC levels associated with increased risks of impaired cognitive and motor functions